MedDataX Logo

Juvenile Essential Arterial Hypertension and Vascular Function

NCT ID: NCT05109013

Last Updated: 2021-11-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main goal of this study is to investigate the association of the juvenile essential arterial hypertension with systemic micro- and macrovascular reactivity and cerebral vascular function, and to examine the potential impact of elevated oxidative stress on this associations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Child, Only Essential Hypertension

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

cerebral circulation child endothelium microcirculation macrocirculation hypertension oxidative stress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NT group - normotensive children

No interventions assigned to this group

HT group - hypertensive children

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy normotensive children and children with essential arterial hypertension

Exclusion Criteria

* secondary arterial hypertension
* other systemic diseases with immunopathology
* neurodegenerative diseasesat
* children that use therapy which has a high impact on vascular or immunological function (immunotherapy, immunosuppressive therapy, sistemic corticosteroid therapy etc..).
Minimum Eligible Age

9 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Josip Juraj Strossmayer University of Osijek

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ines Drenjancevic

Head of Department of Physiology and Immunology Faculty of Medicine Osijek

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martina Kos, MD

Role: PRINCIPAL_INVESTIGATOR

Osijek University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Osijek University Hospital

Osijek, , Croatia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Croatia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Martina Kos, MD

Role: CONTACT

Phone: +385981748381

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Martina Kos, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2158-61-07-21-06

Identifier Type: -

Identifier Source: org_study_id